FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.
FDA approved the first new kind of pain medication in 27 years. Here’s how it works
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
healthday1d
FDA Approves First New Non-Opioid Pain Pill in Decades
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...
clinicalpainadvisor.com1d
Chronic Pain Among Women in Rheumatology — Prioritizing Unmet Needs
Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.
clinicalpainadvisor.com1d
Chronic Postoperative Pain Remains Common Despite Multimodal Analgesia
Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The Healthy on MSN2d
11 Causes of Pain on the Outer Side of Your Foot
Have outer foot pain? Here are common causes of pain on the outer side of your foot, the symptoms to watch for, and how to treat it.
KCBS Radio San Francisco on MSN3d
As Prescribed: The evolving landscape of chronic pain treatment
Chronic pain affects approximately 1 in 5 Americans, and yet it remains one of the most misunderstood and challenging medical ...
News Medical4d
New brain biomarker identifies pain sensitivity and may predict chronic pain risk
A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...